Literature DB >> 168258

The control exerted by thymic hormone (THF) on cellular cAMP levels and immune reactivity of spleen cells in the MLC assay.

A I Kook, N Trinin.   

Abstract

We have shown previously that THF induces immunocompetence in lymphoid cells through the control of cellular cAMP levels and DNA synthesis. By the use of a one-way MLC assay it was now shown that the exposure of spleen cells to THF is accompanied by an increase, in the proliferative response of the responding cells. These effects are mediated by regulation of cellular levels of cAMP during the course of the MLC response. Thus, substances which modify cellular levels of cAMP such as DBcAMP, theophylline, and imidazole change the reactivity of cells exposed to THF in the MLC assay. It was also found here that cellular cAMP levels are critical in controlling the reactivity of normal spleen cells in the absence of THF. It is suggested that THF increases the number of competent cells in the spleen cell population capable of responding to antigenic stimulation in the MLC assay.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168258

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Amplification of the proliferative response to alloantigen by a factor present in an extract of syngeneic thymic lymphoid cells.

Authors:  P W Wright; S M Loop
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  New approaches to immunotherapy: thymomimetic drugs.

Authors:  S Specter; J W Hadden
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Experimental study on effects of iron deficiency anemia on immune function.

Authors:  L Q Tian; Q H Zhu
Journal:  J Tongji Med Univ       Date:  1987

4.  Lipopolysaccharide-induced activation of suppressor cells: reversal by an agent which alters cyclic nucleotide metabolism.

Authors:  R A Winchurch; C Hilberg; W Birmingham; A M Munster
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

5.  Studies on monoclonal anti-isotypic and anti-idiotypic antibodies against leukemia and myeloma: V. The effects of monoclonal antibodies and interferon on the levels of cyclic nucleotides in leukemic cell lines.

Authors:  G X Shen; J F Shao; T X Li; X L Wang; H F Zhu; N Su; Y Zhang; D F Yang
Journal:  J Tongji Med Univ       Date:  1992

6.  Enhancement of natural killer cell activity in mice by treatment with a thymic factor.

Authors:  F Bistoni; M Baccarini; P Puccetti; P Marconi; E Garaci
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Enrichment of in vitro and in vivo immunologic activity of purified fractions of calf thymic hormone.

Authors:  Y Yakir; A I Kook; N Trainin
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.